Tourmaline Bio (NASDAQ:TRML) Rating Reiterated by Leerink Partnrs
Leerink Partnrs reaffirmed their outperform rating on shares of Tourmaline Bio (NASDAQ:TRML – Free Report) in a report issued on Thursday morning, PriceTargets.com reports. Leerink Partnrs also issued estimates for Tourmaline Bio’s FY2026 earnings at ($4.00) EPS. TRML has been the subject of a number of other reports. Piper Sandler started coverage on Tourmaline Bio […]
More Stories
Lupin Part 4: Release Date, Cast Members, and Trailer
One of the most popular and engaging mystery thriller series, Lupin, is returning for its fourth part. The series was...
Let’s Talk About Chu Season 2: Release Date, Cast, and More
The romantic-comedy Taiwanese series Let’s Talk About Chu has become one of the most talked-about series since its release in...
Office Romance is Released! Watch Jennifer Lopez and Brett Goldstein’s Exotic Romance
Looking for a romantic-comedy film to watch with your partner or loved ones this weekend? Jennifer Lopez’s recent film, Office...
The Quiet Logistics Shift Changing How Shoppers Collect Fresh Food
Nobody talks about this, but it’s happening everywhere. The way grocery stores handle order collection is changing. Not in a...
Why Offices Sound Worse Than Ever, And the Engineering Fix Hiding in Plain Sight
Open-plan offices were meant to feel modern, bright, and collaborative. In reality, many feel like a mix of café, hallway,...
Ice Age 6: Boiling Point- Release Date, Voice Artist, and Synopsis
Hello, Ice Age fans! Your favourite animated animal movie is returning to the US theaters. Ice Age 6, or Ice...